National Guideline Clearinghouse | Denosumab for the prevention of skeletal-related events in adults with bone metastases from solid tumours.

full-text ►
National Guideline Clearinghouse | Denosumab for the prevention of skeletal-related events in adults with bone metastases from solid tumours.

January 7, 2013

Guideline Title

Denosumab for the prevention of skeletal-related events in adults with bone metastases from solid tumours.

 

Bibliographic Source(s)

National Institute for Health and Clinical Excellence (NICE). Denosumab for the prevention of skeletal-related events in adults with bone metastases from solid tumours. London (UK): National Institute for Health and Clinical Excellence (NICE); 2012 Oct. 56 p. (Technology appraisal guidance; no. 265).

 

Guideline Status

This is the current release of the guideline.